(NASDAQ: LIVN) Livanova's forecast annual revenue growth rate of 4.7% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.67%.
Livanova's revenue in 2025 is $1,309,329,000.On average, 2 Wall Street analysts forecast LIVN's revenue for 2025 to be $74,907,212,049, with the lowest LIVN revenue forecast at $74,737,948,722, and the highest LIVN revenue forecast at $75,076,475,375. On average, 3 Wall Street analysts forecast LIVN's revenue for 2026 to be $78,226,957,287, with the lowest LIVN revenue forecast at $76,960,212,394, and the highest LIVN revenue forecast at $79,187,936,172.
In 2027, LIVN is forecast to generate $82,032,652,075 in revenue, with the lowest revenue forecast at $81,628,604,135 and the highest revenue forecast at $82,436,700,015.